JWH-019
Chemical compound
From Wikipedia, the free encyclopedia
JWH-019 is an analgesic chemical from the naphthoylindole family that acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is the N-hexyl homolog of the more common synthetic cannabinoid compound JWH-018. Unlike the butyl homolog JWH-073, which is several times weaker than JWH-018, the hexyl homolog is only slightly less potent, although extending the chain one carbon longer to the heptyl homolog JWH-020 results in dramatic loss of activity. These results show that the optimum side chain length for CB1 binding in the naphthoylindole series is the five-carbon pentyl chain, shorter than in the classical cannabinoids where a seven-carbon heptyl chain produces the most potent compounds. This difference is thought to reflect a slightly different binding conformation adopted by the naphthoylindole compounds as compared to the classical cannabinoids, and may be useful in characterizing the active site of the CB1 and CB2 receptors.[2][3][4]
- CA: Schedule II
- DE: Anlage II (Authorized trade only, not prescriptible)
- UK: Class B
- US: Schedule I
- Illegal in Sweden, I-N (Poland)[1]
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H25NO |
| Molar mass | 355.481 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Legal status
China
As of October 2015 JWH-019 is a controlled substance in China.[5]
Poland
In Poland, JWH-019 is I-N (Poland).[1]
Sweden
JWH-019 is illegal in Sweden.
United Kingdom
JWH-019 is Class B in the United Kingdom.
United States
JWH-019 is a Schedule I controlled substance, controlled federally in the United States.[6]